Fennec Pharmaceuticals (FENC) EPS (Weighted Average and Diluted) Growth (3y) (2013 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -25,782.97% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 41.33% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 14.33% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -1.99% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 45.47% |
| 10 | Fennec Pharmaceuticals | 281.48 Mn | 244.70 Mn | 7.67 Mn | 13.82% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 13.82% |
| Sep 30, 2025 | 59.89% |
| Jun 30, 2025 | 16.65% |
| Mar 31, 2025 | 34.14% |
| Dec 31, 2024 | 22.22% |
| Sep 30, 2024 | -9.49% |
| Jun 30, 2024 | -10.06% |
| Mar 31, 2024 | 62.33% |
| Dec 31, 2023 | 5.90% |
| Sep 30, 2023 | 33.68% |
| Jun 30, 2023 | 0.00% |
| Mar 31, 2023 | -6.58% |
| Sep 30, 2022 | -51.02% |
| Jun 30, 2022 | 7.49% |
| Mar 31, 2022 | -44.22% |
| Sep 30, 2021 | -4.55% |
| Jun 30, 2021 | -2.33% |
| Mar 31, 2021 | -25.99% |
| Sep 30, 2020 | -16.96% |
| Jun 30, 2020 | -24.05% |
| Mar 31, 2020 | -46.85% |
| Sep 30, 2019 | -31.04% |
| Jun 30, 2019 | -58.74% |
| Mar 31, 2019 | 76.52% |
| Sep 30, 2018 | -141.01% |
| Jun 30, 2018 | -91.29% |
| Mar 31, 2018 | -122.40% |
| Sep 30, 2017 | -91.29% |
| Jun 30, 2017 | -11.20% |
| Mar 31, 2017 | 43.35% |
| Sep 30, 2016 | -88.57% |
| Jun 30, 2016 | -18.27% |
| Mar 31, 2016 | -23.44% |
| Sep 30, 2015 | 26.16% |
| Jun 30, 2015 | 92.61% |
| Mar 31, 2015 | -55.04% |
| Dec 31, 2014 | 26.07% |
| Sep 30, 2014 | 40.50% |
| Jun 30, 2014 | -52.01% |
| Mar 31, 2014 | -55.18% |
| Dec 31, 2013 | 7.76% |
| Sep 30, 2013 | 48.70% |
| Jun 30, 2013 | -23.04% |